Seipasa is set to invest 4 million Euros in its new facilities at its industrial complex in Valencia

May 11, 2022
Seipasa to invest 4 million in new facilities
Rendering of the design of Seipasa's new production plant and head offices in L'Alcúdia, Valencia, on which work has already commenced.

Seipasa, the Spanish company specialised in the development, formulation and production of bioinsecticides, biofungicides, biostimulants and fertilizers, has begun work on the construction of its new facilities inside its industrial complex in L'Alcúdia, Valencia, Spain.

A 4 million Euro investment has been announced to equip the company with the facilities and technology required to launch its new product line onto the market.

The new building, located at the junction between Avenida Ronda de Europa and Calle Gutiérrez Mellado, on La Creu Industrial Estate in L'Alcúdia, will also house the company's new head offices. 

These facilities will give Seipasa an additional 4,400 m2 of space, of which 2,900 m2 will be devoted to the new production plant and the remaining 1,500 m2 to working space. 

The new building, equipped with cutting-edge technology, will be totally sustainable in terms of use of materials and efficient energy consumption. Building work has just started and it is expected to be completed during the first quarter of 2023

New line adhering to the Natural Technology® model

Seipasa CEO, Pedro Peleato, explained that the start of construction work marks the first step towards the launch of the new product line the company is working on.

"For many years now our R+D+I department has been researching the formulation and development of a new product line that will be a real and effective alternative to the synthetic herbicides currently on the market. The work carried out by Seipasa has involved balancing all the pieces on the board, from technology to costs and regulations, so that this alternative can come true in the hands of farmers", Mr Peleato stated.

Seipasa's CEO added that, "in the case of the EU, we are talking about the potential withdrawal, in the short and medium term, of 40% of the active substances currently available. "It is thought that 2 out of every 3 conventional phytosanitary products will cease to exist. This scenario forces companies to pour all of their talent and innovation into developing new alternatives hand in hand with biocontrol and, in the specific case of Seipasa, based on our Natural Technology® model".

This will be the third major extension to the company's facilities in 3 years, following those carried out in 2018 and 2021, further reinforcing the company’s innovating, manufacturing and operating capacity.